Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy.

Aebersold, Daniel M.; Froehlich, Susanne C.; Jonczy, Maciej; Beer, Karl T; Laissue, Jean; Greiner, Richard H.; Djonov, Valentin (2002). Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiotherapy and oncology, 63(3), pp. 275-283. Elsevier 10.1016/s0167-8140(02)00131-7

[img] Text
1-s2.0-S0167814002001317-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (344kB) | Request a copy

BACKGROUND AND PURPOSE

Epidermal growth factor receptor (EGFR) has been implicated in cellular responses to ionizing radiation and represents a major target for current radiosensitizing strategies. We wished to ascertain whether a correlation existed between the expression of EGFR, transforming growth factor-alpha (TGFalpha) and platelet-derived growth factors A and B (PDGF-A and PDGF-B) and treatment outcome in a group of patients with oropharyngeal cancer who had undergone curative radiation therapy. We also assessed the relationship existing between each of the aforementioned proteins and intratumoral microvessel densities (IMD) which have been previously reported (Int J Radiat Oncol Biol Phys 2000;48:17-25.

MATERIALS AND METHODS

Pretherapeutic tumor biopsies from 95 patients were immunohistochemically stained and their immunoreactivities evaluated semi-quantitatively. The statistical analyses included Cox regression for calculating risk ratios of survival endpoints and logistic regression for determining odds ratios for the development of distant metastasis.

RESULTS

Local tumor control as well as disease-free and overall survival were independent of protein expression levels, whereas combined TGFalpha and EGFR immunoreactivities were closely related to IMD (P = 0.003). The expression levels of these two proteins were also correlated to each other (P = 0.015). Expression of PDGF-B occurred in 54% of cases and was associated with an increase in the risk of developing distant metastasis (P = 0.011).

CONCLUSIONS

Tumoral levels of TGFalpha, EGFR and PDGF-A/B are not predictive of radioresponsiveness in oropharyngeal cancers. The association between IMD and immunoreactivity for TGFalpha and EGFR indicates the involvement of these proteins in the promotion of angiogenesis in these tumors. PDGF-B should be further evaluated as a prognostic marker for squamous cell cancer of the head and neck.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Aebersold, Daniel; Laissue, Jean; Greiner, Richard and Djonov, Valentin Georgiev

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

0167-8140

Publisher:

Elsevier

Language:

English

Submitter:

David Christian Haberthür

Date Deposited:

04 Feb 2021 14:48

Last Modified:

04 Feb 2021 14:48

Publisher DOI:

10.1016/s0167-8140(02)00131-7

PubMed ID:

12142091

BORIS DOI:

10.48350/149305

URI:

https://boris.unibe.ch/id/eprint/149305

Actions (login required)

Edit item Edit item
Provide Feedback